The prevalence of HIV infection among male prison inmates is significantly higher than in the U.S. population. Adequate planning to ensure continued medication adherence and continuity of care after release is important for this population. This study describes the prerelease characteristics of 162 incarcerated HIV-positive men (40 from jails and 122 from prisons). The results include a demographic description of the sample and the participants’ sexual risk behaviors, substance use, health status and HIV medication adherence, health care utilization, mental health, and family and social support. The results highlight a potentially high level of need for services and low levels of support and social connectedness. Postrelease planning should include support for improving HIV medication adherence as well as reducing both sexual and injection drug-related transmission risk for these individuals.
BaillargeonJ., GiordanoT. P., RichJ. D., WuZ. H., WellsK., PollackB. H., PaarD. P. (2009). Accessing antiretroviral therapy following release from prison. Journal of the American Medical Association, 301, 848–857.
2.
BurnsM. J., FeasterD. J., MitraniV. B., OwC., SzapocznikS. (2008). Stress processes of HIV+ African American mothers: Moderating effect of drug abuse history. Stress, Anxiety and Coping, 21, 95–116.
3.
CainL. E., ColeS. R., ChmielJ. S., MargolickJ. B., RinaldoC. R., DetelsR. (2006). Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters. American Journal of Epidemiology, 163, 310–315.
4.
CambianoV., RodgerA. J., PhillipsA. N. (2011). “Test-and-treat”: The end of the HIV epidemic?. Current Opinion in Infectious Diseases, 24, 19–26.
5.
ChesneyM. A., IckovicsJ. R., ChambersD. B., GiffordA. L., NeidigJ., ZwicklB., WuA. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient care committee & adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG). AIDS Care, 12, 255–266.
6.
ColeS. R., HernanM. A., AnastosK., JamiesonB. D., RobinsJ. M. (2007). Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. American Journal of Epidemiology, 166, 219–227.
7.
DerogatisL. R. (1993). Brief symptom inventory: Administration, scoring, and procedures manual. Minneapolis, MN: National Computer Systems.
8.
DieffenbachC. W., FauciA. S. (2009). Universal voluntary testing and treatment for prevention of HIV transmission. Journal of the American Medical Association, 301, 2380–2382.
9.
DraineJ., WolffN., JacobyJ. E., HartwellS., DuclosC. (2005). Understanding community re-entry of former prisoners with mental illness: A conceptual model to guide new research. Behavioral Sciences and the Law, 23, 689–707.
10.
GranichR. M., GilksC. F., DyeC., De CockK. M., WilliamsB. G. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet, 373, 48–57.
11.
GrinsteadO., ZackB., FaigelesB. (2001). Reducing postrelease risk behavior among HIV seropositive prison inmates: The health promotion program. AIDS Education and Prevention,13, 109–119.
12.
GrinsteadO. A., ZackB., FaigelesB., GrossmanN., BleaL. (1999). Reducing postrelease HIV risk among male prison inmates: A peer-led intervention. Criminal Justice and Behavior, 26, 453–465.
13.
HarriganP. R., HoggR. S., DongW. W. Y., YipB., WynhovenB., WoodwardJ.…MontanerJ. S. (2005). Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. Journal of Infectious Diseases, 191, 339–347.
14.
HendershotC. S., StonerS. A., PantaloneD. W., SimoniJ. M. (2009). Alcohol use and antiretroviral adherence: Review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 52, 180–202.
15.
HogeS. K., BuchananA. W., KovasznayB. M., RoskesE. J. (2009). Task force report: Outpatient services for the mentally ill involved in the criminal justice system. Arlington, VA: American Psychiatric Association. Retrieved from http://www.law.uchicago.edu/files/file/outpatient-crimjustice.pdf
16.
LehavotK., HuhD., WaltersK. L., KingK. M., AndrasikM. P., SimoniJ. M. (2011). Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence. AIDS Patient Care and STDs, 25, 181–189.
MellowJ., GreifingerR. (2008). The evolving standard of decency: Postrelease planning?. Journal of Correctional Health Care, 14, 21–30.
19.
MontanerJ. S., HoggR., WoodE., KerrT., TyndallM., LevyA. R., HarriganP. R. (2006). The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet, 368, 531–536.
20.
MoseleyK., TewksburyR. (2006). Prevalence and predictors of HIV risk behaviors among male prison inmates. Journal of Correctional Health Care, 12, 132–144.
21.
PagliaroL. A., PagliaroA. M. (1992). Sentenced to death? HIV infection and AIDS in prison: Current and future concerns. Canadian Journal of Criminology, 34, 201–214.
22.
PalellaF. J., DelaneyK. M., MoormanA. C., LovelessM. O., FuherJ., SattenG. A.,… the HIV Outpatient Study Investigators. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853–860.
23.
PetersiliaJ. (2000). Challenges of prisoner reentry and parole in California. CPRC Brief 12(3). Berkeley, CA: University of California, California Policy Research Center.
24.
Pettus-DavisC., ScheyettA. M., HaileyD., GolinC., WohlD. (2009). From the “streets” to “normal life”: Assessing the role of social support in release planning for HIV-positive and substance-involved prisoners. Journal of Offender Rehabilitation, 48, 367–387.
25.
PowerC., SelnesO. A., GrimJ. A., McArthurJ. C. (1995). HIV Dementia scale: A rapid screening test. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 8, 273–278.
26.
RemeinR. H., StirrattM. J., DogninJ., DayE., El-BasselN., WarneP. (2006). Moving from theory to practice: Implementing an effective dyadic intervention to improve antiretroviral adherence for clinic patients. Journal of Acquired Immune Deficiency Syndrome, 43, S69–S78.
27.
ReznickO. G., McCartneyK., GregorichS., ZackB., FeasterD. J. (2013). An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among prisoners being released to the community. Journal of Correctional Health Care, 19, 178–193.
28.
RhineE., MatthewsJ. R. II, SampsonL. A., DaleyH. (2003). Citizens’ circles: Community collaboration in re-entry. Corrections Today, 65, 52–54.
29.
RobertsC. S., FeethamS. L. (1982). Assessing family functioning across three areas of relationships. Nursing Research, 31, 231–235.
SafrenS. A., O’CleirighC., TanJ. Y., RaminaniS. R., ReillyL. C., OttoM. W., MayerK. H. (2009). A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychology, 28, 1–10.
32.
SealD. W. (2005). HIV-related issues and concerns for imprisoned persons throughout the world. Current Opinion in Psychiatry, 18, 530–535.
33.
SealD. W., MargolisA. D., SosmanJ., KacanekD., BinsonD. (2003). HIV and STD risk behavior among 18- to 25-year-old men released from U.S. prisons: Provider perspectives. AIDS and Behavior, 7, 131–141.
34.
SimoniJ. M., PearsonC. R., PantaloneD. W., MarksG., CrepazN. (2006). Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RAN viral load: A meta-analytic review of randomized controlled trials. Journal of Acquired Immune Deficiency Syndrome, 43, S23–S35.
35.
SimoniJ. M., SafrenS. A., ManhartL. E., LydaK., GrossmanC. I., RaoD.…WilsonI. B. (2011). Challenges in addressing depression in HIV research: Assessment, cultural context, and methods. AIDS Behavior, 15, 376–388.
36.
StephensonB. L., WohlD. A., GolinC. E., TienH-C., StewartP., KaplanA. H. (2005). Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Reports, 120, 84–88.
VervoortS. C. J. M., BorleffsJ. C. C., HoepelmanA. I. M., GrypdonckM. H. F. (2007). Adherence in antiretroviral therapy: A review of qualitative studies. AIDS, 21, 271–281.
39.
VisherC. A., Debus-SherrilS. A., YahnerJ. (2011). Employment after prison: A longitudinal study of former prisoners. Justice Quarterly, 28, 698–718.
40.
WolffN., DraineJ. (2004). Dynamics of social capital of prisoners and community reentry: Ties that bind?. Journal of Correctional Health Care, 10, 457–490.
41.
ZimetG., DahlemN., ZimetS., FarleyG. (1988). The multidimensional scale of perceived social support. Journal of Personality Assessment, 52, 30–41.
